COG2 and metabolic syndrome: Their receptor-mediated uptake of LDL-C, cholesteryl ester transfer protein activity, and hepatic ApoB-100 and intestinal ApoB-48 secretion, comparable to those described in humans [56,57], allow for studying the effect of a food supplement on HFD-induced dyslipidemia.